A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-27.93%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$108M
AUM Growth
+$108M
Cap. Flow
+$256K
Cap. Flow %
0.24%
Top 10 Hldgs %
90.19%
Holding
19
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

1
AUPH icon
Aurinia Pharmaceuticals
AUPH
$256K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 89.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$19.7M 18.31% 1,301,413 – –
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$19M 17.69% 2,080,595 – –
TARA icon
3
Protara Therapeutics
TARA
$120M
$15.6M 14.46% 2,017,872 – –
SIEN
4
DELISTED
Sientra, Inc.
SIEN
$15M 13.98% 2,199,012 – –
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$6.72M 6.25% 383,935 – –
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5.06M 4.7% 945,757 – –
TBRA
7
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$4.79M 4.45% 589,244 – –
INNL
8
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$4.67M 4.34% 555,555 – –
EVAR
9
DELISTED
Lombard Medical, Inc.
EVAR
$3.75M 3.49% 3,473,452 – –
CLLS
10
Cellectis
CLLS
$258M
$2.74M 2.54% 100,000 – –
RGLS
11
DELISTED
Regulus Therapeutics
RGLS
$2.27M 2.1% 327,350 – –
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
$2.16M 2.01% 1,600,000 – –
ADAP
13
Adaptimmune Therapeutics
ADAP
$15.6M
$2.03M 1.88% 250,000 – –
ANTH
14
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.58M 1.47% 437,994 – –
DERM
15
DELISTED
Dermira, Inc.
DERM
$1.45M 1.35% 70,000 – –
CCXI
16
DELISTED
ChemoCentryx, Inc.
CCXI
$533K 0.5% 215,000 – –
ACHV icon
17
Achieve Life Sciences
ACHV
$152M
$271K 0.25% 396,104 – –
AUPH icon
18
Aurinia Pharmaceuticals
AUPH
$1.58B
$256K 0.24% +88,307 New +$256K
EPRS
19
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$21K 0.02% 7,896 – –